Video

Eileen T. Lake, PhD: The Lasting Impact of COVID-19 on Nursing

Author(s):

Many predict there will be a lasting labor shortage in nursing in the future.

The ripple effects of the COVID-19 pandemic might be felt in nursing for years to come.

Not only were nurses burdened by the high volumes of very sick patients and a political climate that made it difficult for them to work, but also many decided they no longer wanted to deal with the stress of the job, leading to a labor shortage.

There also might be prospective nurses who survey the situation and decide they no longer wanted to pursue the profession as a career choice.

In an interview with HCPLive®, Eileen T. Lake, PhD, MSN, MA, BSN, FAAN, the Jessie M. Scott Endowed Term Chair in Nursing and Health Policy, Professor of Nursing and Sociology, and Associate Director of the Center for Health Outcomes and Policy Research at the University of Pennsylvania School of Nursing, explained how the events of the last 18 months might have a severe long-term impact on the nursing profession in general.

Lake said there are ways to balance the pressures of the job with limiting the distress on individual nurses by ensuring there is enough personal protective equipment (PPE) and doing the best they can in making sure enough nurses are staffed at a given time.

Related Videos
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Akif Shameem, MD: Generalized Anxiety Disorder Linked to Longer Hospitals in Children with IBD
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Thumbnail for schizophrenia special report around approval of Cobenfy.
© 2024 MJH Life Sciences

All rights reserved.